Mild Cognitive Impairment (MCI) clinical trials in Maryland
18 active Mild Cognitive Impairment (MCI) trials with a site in Maryland. Describe your situation to see which ones look like a fit.
- Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
- Music Therapy for Patients With Alzheimer's Disease
- Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)
- Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone
- Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
- Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
- PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
- PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
- Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
- Crownlands Observing Progression With Neurons Study
- e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most
- Working Memory and Physical Exercise Training in Patients With Mild Cognitive Impairment
- Personalized Closed-Loop Brain Stimulation for Patients With Mild Cognitive Impairment
- Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer s Disease
- Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
- Fall Prevention in Mild Cognitive Impairment
- Alzheimer's Disease Neuroimaging Initiative 4
- Longitudinal Early-onset Alzheimer's Disease Study Protocol
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.